StoxAjanta Pharmaceuticals vs Aster DM Quality Care: share price & financials comparison
NSE: AJANTPHARM vs ASTERDM · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Ajanta Pharmaceuticals vs Aster DM Quality Care at a glance
Ajanta Pharmaceuticals (AJANTPHARM) has a market capitalisation of ₹41,165 Cr, against ₹62,979 Cr for Aster DM Quality Care (ASTERDM). Over the past year Ajanta Pharmaceuticals has returned +25.8%, compared with +4.9% for Aster DM Quality Care. On valuation, Ajanta Pharmaceuticals trades at a lower P/E of 32.7 versus 133.8. Ajanta Pharmaceuticals earns a higher return on equity (25.9% vs 6.0%). Ajanta Pharmaceuticals comes out ahead on size, valuation, profitability, financial health and technicals. Aster DM Quality Care comes out ahead on growth and momentum. Across the scored metrics below, Ajanta Pharmaceuticals leads on 11 and Aster DM Quality Care on 6. On StoxGud's 10-point checklist, Ajanta Pharmaceuticals scores 9/10 and Aster DM Quality Care scores 5/10.
| Metric | Ajanta Pharmaceuticals | Aster DM Quality Care |
|---|---|---|
| Size | ||
| Market cap | ₹41,165 Cr | ₹62,979 Cr |
| Revenue (latest FY) | ₹5,453 Cr | ₹4,643 Cr |
| Net profit (latest FY) | ₹1,056 Cr | ₹388 Cr |
| Valuation | ||
| P/E | 32.7 | 133.8 |
| P/B | 8.47 | 8.08 |
| Dividend yield | 0.85% | 0.09% |
| Profitability | ||
| Return on equity | 25.9% | 6.0% |
| Net profit margin | 20.2% | 7.2% |
| Operating margin | 27.1% | 21.1% |
| Growth | ||
| Revenue growth (YoY) | +32.5% | +136.3% |
| Net profit growth (YoY) | +49.2% | +138.2% |
| Revenue CAGR (multi-year) | +13.5% | -11.6% |
| Financial health | ||
| Debt to equity | 0.02 | 0.51 |
| Momentum | ||
| 1-month return | -1.3% | +4.7% |
| 1-year return | +25.8% | +4.9% |
| 3-year CAGR | +20.7% | +28.3% |
| 5-year CAGR | +17.8% | +28.4% |
| 10-year CAGR | +11.2% | — |
| Distance from 52W high | -11.7% | -16.9% |
| Technicals | ||
| RSI (14) | 50 | 76 |
| Price vs 200-day avg | +2.9% | +0.5% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Ajanta Pharmaceuticals | Aster DM Quality Care |
|---|---|---|
| Price above 50-day average | ✗ | ✓ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✓ | ✗ |
| RSI in healthy 40–70 zone | ✓ | ✗ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✓ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✓ | ✗ |
| P/E below industry median | ✓ | ✗ |
| Score | 9/10 | 5/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Ajanta Pharmaceuticals or Aster DM Quality Care?
Ajanta Pharmaceuticals has a market cap of ₹41,165 Cr and Aster DM Quality Care has a market cap of ₹62,979 Cr as of 13 Nov 2026.
Which has a lower P/E, Ajanta Pharmaceuticals or Aster DM Quality Care?
Ajanta Pharmaceuticals has the lower P/E: Ajanta Pharmaceuticals trades at 32.7 and Aster DM Quality Care at 133.8.
Which gave better returns in the last year, Ajanta Pharmaceuticals or Aster DM Quality Care?
Ajanta Pharmaceuticals did better: Ajanta Pharmaceuticals returned +25.8% and Aster DM Quality Care returned +4.9% over one year.
What is the difference between Ajanta Pharmaceuticals and Aster DM Quality Care?
Both are NSE-listed companies in Healthcare. They are about the same size by market cap (₹41,165 Cr vs ₹62,979 Cr). In the latest financial year Ajanta Pharmaceuticals reported revenue of ₹5,453 Cr and Aster DM Quality Care ₹4,643 Cr. Operating margin is 27.1% for Ajanta Pharmaceuticals and 21.1% for Aster DM Quality Care. Debt to equity is 0.02 for Ajanta Pharmaceuticals and 0.51 for Aster DM Quality Care.
Which is better, Ajanta Pharmaceuticals or Aster DM Quality Care?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Ajanta Pharmaceuticals leads on 11 and Aster DM Quality Care on 6. Ajanta Pharmaceuticals is ahead on size, valuation, profitability, financial health and technicals. Aster DM Quality Care is ahead on growth and momentum. On StoxGud's rules-based checklist Ajanta Pharmaceuticals scores 9/10 and Aster DM Quality Care scores 5/10. This is information, not advice: consult a SEBI-registered adviser before investing.